Table 2 Logistic regression analysis of the relationship between RPLP2 expression levels and clinicopathological characteristics in HCC patients
Characteristics | Total (N) | OR (95% CI) | P value |
|---|---|---|---|
Age (> 60 vs. ≤ 60) | 373 | 0.602 (0.400–0.907) | 0.015 |
Race (Black or African American and White vs. Asian) | 362 | 0.358 (0.233–0.549) | < 0.001 |
Pathologic stage (Stage III and Stage IV vs. Stage I and Stage II) | 350 | 1.369 (0.845–2.219) | 0.202 |
Pathologic T stage (T3 and T4 vs. T1 and T2) | 371 | 1.445 (0.900–2.319) | 0.128 |
Pathologic N stage (N1 vs. N0) | 258 | 0.854 (0.118–6.157) | 0.876 |
Pathologic M stage (M1 vs. M0) | 272 | 2.432 (0.250–23.683) | 0.444 |
Histologic grade (G3 and G4 vs. G1 and G2) | 369 | 2.842 (1.829–4.417) | < 0.001 |
Residual tumor (R1 and R2 vs. R0) | 345 | 0.815 (0.314–2.117) | 0.674 |
Tumor status (with tumor vs. tumor free) | 355 | 1.651 (1.081–2.523) | 0.020 |
Weight (> 70 vs. ≤ 70) | 346 | 0.353 (0.228–0.546) | < 0.001 |
Adjacent hepatic tissue inflammation (mild and severe vs. none) | 237 | 1.389 (0.830–2.324) | 0.211 |
Vascular invasion (yes vs. no) | 318 | 1.373 (0.864–2.183) | 0.180 |
AFP (ng/mL) (> 400 vs. ≤ 400) | 280 | 4.094 (2.190–7.655) | < 0.001 |